You are here

Theravance

This Week in Biotech

Motley Fool

Sun, 12/22/13 - 12:28 pm

Ariad Pharmaceuticals

Gilead Sciences

Cubist Pharmaceuticals

Jazz Pharmaceuticals

FDA approves once-a-day inhaler combination drug from Glaxo, Theravance

Yahoo/AP

Wed, 12/18/13 - 02:39 pm

Glaxo, Theravance Launch Relvar Ellipta in Japan

Motley Fool

Tue, 12/10/13 - 09:15 am

Theravance, Glaxo COPD Drug Does Well In Asthma

investors.com

Sat, 12/7/13 - 12:52 pm

GSK, Theravance asthma drug shows improved lung function in study

Yahoo/Reuters

Fri, 12/6/13 - 10:07 am

3 Biopharmas Hoping for Good News From the FDA

Motley Fool

Wed, 12/4/13 - 03:45 pm

3 Can't-Miss FDA Actions Coming in December

Motley Fool

Tue, 11/26/13 - 04:42 pm

Gilead Sciences

Bristol-Myers Squibb

4 Biotech Stocks With Upcoming FDA Decision Dates

Seeking Alpha

Mon, 11/25/13 - 10:22 am

Glaxo and Theravance Get European Marketing Approval for Relvar Ellipta

Motley Fool

Tue, 11/19/13 - 08:11 am

Novartis - Make Money From COPD Opportunity

Seeking Alpha

Tue, 10/8/13 - 05:06 pm

Ultibro Breezhaler

A Reshuffle in a $27 Billion Market

Motley Fool

Sun, 09/29/13 - 01:48 pm

Theravance, GSK get positive opinion from EMA for Relvar Ellipta

The Fly on the Wall

Thu, 09/19/13 - 01:48 pm

Could a Pair of Respiratory Disease Treatments Save This Big Pharma?

Motley Fool

Tue, 09/17/13 - 09:29 am

Theravance confirms FDA panel recommends approval of Theravance-Glaxo lung drug

Yahoo/Fly on the Wall

Tue, 09/10/13 - 04:28 pm

This Week in Biotech

Motley Fool

Sun, 09/8/13 - 11:09 am

Rockwell Medical

Glaxo-Theravance Lung Drug Shows Strong Efficacy, FDA Say

Bloomberg

Sat, 09/7/13 - 11:41 am

Glaxo-Theravance Lung Drug Shows Strong Efficacy, FDA Say

Bloomberg

Fri, 09/6/13 - 10:16 am

Theravance says lung disease drug TD-4208 succeeded in a midstage clinical trial

Yahoo/AP

Thu, 09/5/13 - 06:51 pm

This Week in Biotech

Motley Fool

Sun, 08/18/13 - 11:58 am

Osiris Therapeutics

Gilead Sciences

Pages